Want to join the conversation?
$BAX's sales within the U.S. for 4Q15 rose 1% to $1.1Bil, while international sales totaled $1.5Bil, representing a 2% increase on a constant currency basis, and 12% decline on a reported basis. Adjusting for impact of FX and generic market entrant in the U.S. for its oncology injectable, cyclophosphamide, $BAX's global sales rose 4%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?